# Travatan Versus Timoptic in Treating Open-angle Glaucoma or Ocular Hypertension

> **NCT00763061** · PHASE4 · COMPLETED · sponsor: **Alcon Research** · enrollment: 111 (actual)

## Conditions studied

- Glaucoma

## Interventions

- **DRUG:** Travoprost 0.004% Ophthalmic Solution (Travatan)
- **DRUG:** Timolol 0.5% Ophthalmic Solution (Timoptic)

## Key facts

- **NCT ID:** NCT00763061
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 111 (ACTUAL)
- **Last updated:** 2010-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00763061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00763061, "Travatan Versus Timoptic in Treating Open-angle Glaucoma or Ocular Hypertension". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00763061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*